The mission of the Department of Internal Medicine is as follows:
1.To teach students and physicians in the field of general internal medicine recognizing that it is an integral part of primary care.
2.To provide compassionate, competent, and cost-effective care to the patients.
Through research, attempt to solve existing problems, provoke new understandings, and conduct studies directed towards the relief of human suffering, enhancement of human health, and to the general betterment of the human condition.
There are 9 divisions in the Department of Internal Medicine and the research interests are diverse. For chest division, there are many breakthroughs in lung cancer research. The major interest of research in Hematology Division is the pathogenesis of hematological malignancies, especially the genetic and epigenetic alterations in myelodysplastic syndrome (MDS) and acute myeloid leukemia.
The research activities in Division of Endocrinology and Metabolism include the genetics, epidemiology, diagnosis, treatment and prognosis of thyroid cancer, Graves’ disease, osteoporosis, adrenal disease, diabetes mellitus, insulin resistance and metabolic syndrome. Research in Cardiology include lipid disorders, atherosclerosis, arrhythmias, cellular electrophysiology, hypertension, heart failure and transcatheter therapeutics.
The Chin-Shan Cardiovascular Cohort Study is the most important epidemiological study in Taiwan. Gastric cancer and Helicobacter pylori studies are our important achievements, while our hepatitis and liver cancer research are also famous worldwide.
There are also many good performances in the fields of evidence-based medicine, hemodialysis, peritoneal dialysis, AIDS and other infectious diseases. Major achievements in Rheumatology are Lactoferrin studies and glucose regulated protein 78 studies.